Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients

Psychiatry Research - Neuroimaging

Volumn 171, Issue 1, 2009, Pages 10-19

  Haroon, Ebrahim ^a,c   Watari, Kecia ^a   Thomas, Albert ^b   Ajilore, Olusola ^a   Mintz, Jim ^a   Elderkin Thompson, Virginia ^a   Darwin, Christine ^b   Kumaran, Senthil ^b   Kumar, Anand ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Cognition; Depression; Diabetes mellitus; Magnetic resonance spectroscopy; Myo inositol; Vascular disease

Indexed keywords

INOSITOL;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEPTH PERCEPTION; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HUMAN; MALE; MENTAL PATIENT; NEUROIMAGING; PERCEPTION DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECALL; RECOGNITION; TASK PERFORMANCE; WHITE MATTER;

AGED; COGNITION DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREFRONTAL CORTEX; RECOGNITION (PSYCHOLOGY); SPACE PERCEPTION; VISUAL PERCEPTION;

EID: 57749111467     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2008.03.006     Document Type: Article

References (39)

1. Ajilore O., Haroon E., Kumaran S., Darwin C., Binesh N., Mintz J., Miller J., Thomas M.A., and Kumar A. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 32 (2007) 1224-1231
2. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001) 1069-1078
3. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., and Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Archives of Neurology 61 (2004) 661-666
4. Ashwal S., Holshouser B., Tong K., Serna T., Osterdock R., Gross M., and Kido D. Proton spectroscopy detected myoinositol in children with traumatic brain injury. Pediatric.Research 56 (2004) 630-638
5. Beacher F., Simmons A., Daly E., Prasher V., Adams C., Margallo-Lana M.L., Morris R., Lovestone S., Murphy K., and Murphy D.J. Hippocampal myo-inositol and cognitive ability in adults with Down syndrome: an in vivo proton magnetic resonance spectroscopy study. Archives of General Psychiatry 62 (2005) 1360-1365
6. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Annals of New York Academy of Sciences 508 (1987) 333-348
7. Brand A., Richter-Landsberg C., and Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Developmental Neuroscience 15 (1993) 289-298
8. Coupland N.J., Ogilvie C.J., Hegadoren K.M., Seres P., Hanstock C.C., and Allen P.S. Decreased prefrontal Myo-inositol in major depressive disorder. Biological.Psychiatry 57 (2005) 1526-1534
9. D'Agostino R.B., Wolf P.A., Belanger A.J., and Kannel W.B. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 25 (1994) 40-43
10. Elderkin-Thompson V., Thomas M.A., Binesh N., Mintz J., Haroon E., Dunkin J.J., and Kumar A. Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopy. Neuropsychopharmacology 29 (2004) 2251-2257
11. Elderkin-Thompson V., Kumar A., Mintz J., Boone K., Bahng E., and Lavretsky H. Executive dysfunction and visuospatial ability among depressed elders in a community setting. Archives of Clinical Neuropsychology 19 (2004) 597-611
12. Haase A., Frahm J., Hanicke W., and Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Physics in Medicine and Biology 30 (1985) 341-344
13. Hassing L.B., Grant M.D., Hofer S.M., Pedersen N.L., Nilsson S.E., Berg S., McClearn G., and Johansson B. Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study. Journal of International Neuropsychological Society 10 (2004) 599-607
14. Henson R. A mini-review of fMRI studies of human medial temporal lobe activity associated with recognition memory. The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology 58 (2005) 340-360
15. Jones R.S., and Waldman A.D. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurological Research 26 (2004) 488-495
16. Kim H., McGrath B.M., and Silverstone P.H. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies. Human Psychopharmacology 20 (2005) 309-326
17. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magnetic Resonance in Medicine 14 (1990) 26-30
18. Kollokia V. Performance analysis of automatic techniques for tissue classification in magnetic resonance images of the human brain. Master's Degree (1996), Department of Computer Science, Concordia University, Montreal
19. Kumar A., Thomas A., Lavretsky H., Yue K., Huda A., Curran J., Venkatraman T., Estanonl L., Mintz J., Mega M., and Toga A. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy. American Journal of Psychiatry 159 (2002) 630-636
20. Kumari M., and Marmot M. Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 65 (2005) 1597-1603
21. Launer L.J. Epidemiology of white matter lesions. Topics in Magnetic Resonance Imaging: TMRI 15 (2004) 365-367
22. Lesser I.M., Boone K.B., Mehringer C.M., Wohl M.A., Miller B.L., and Berman N.G. Cognition and white matter hyperintensities in older depressed patients. American Journal of Psychiatry 153 (1996) 1280-1287
23. Linn B.J., Linn B.W., and Gurel L. Cumulative Illness Rating Scale. Journal of American Geriatrics Society 16 (1968) 622-626
24. Lucas, J.A., 2005. Disorders of memory. Psychiatric Clinics of North America 28, 581-97, 594.
25. Luchsinger J.A., Tang M.X., Stern Y., Shea S., and Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. American Journal of Epidemiology 154 (2001) 635-641
26. Lustman P.J., Anderson R.J., Freedland K.E., de G.M., Carney R.M., and Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000) 934-942
27. Meyers J.L., and Meyers K.R. Rey complex figure. Test and recognition trial (RCFT), Professional Manual (1996), Psychological Assessment Resources, Florida
28. Nguyen T.T., Wong T.Y., Islam F.M., Hubbard L., Miller J., Haroon E., Darwin C., Esser B., and Kumar A. Is depression associated with microvascular disease in patients with type 2 diabetes?. Depression and Anxiety 25 11 (2008) E158-E162
29. Osterrieth P.A. Le test de copie dune figure complexe. Archives de Psycghologie 30 (1944) 206-356
30. Oz G., Tkac I., Charnas L.R., Choi I.Y., Bjoraker K.J., Shapiro E.G., and Gruetter R. Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 64 (2005) 434-441
31. Provencher S.W. Estimations of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 (1993) 672-679
32. Ranganath C. Working memory for visual objects: complementary roles of inferior temporal, medial temporal, and prefrontal cortex. Neuroscience 139 (2006) 277-289
33. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Archives de Psychologie 28 (1941) 286-340
34. Robertson N.J., Lewis R.H., Cowan F.M., Allsop J.M., Counsell S.J., Edwards A.D., and Cox A.J. Early increases in brain myo-inositol measured by proton magnetic resonance spectroscopy in term infants with neonatal encephalopathy. Pediatric Research 50 (2001) 692-700
35. Schupf N., Tang M.X., Albert S.M., Costa R., Andrews H., Lee J.H., and Mayeux R. Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology 65 (2005) 1218-1226
36. Strachan M.W., Deary I.J., Ewing F.M., and Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20 (1997) 438-445
37. Thomas M.A., Yue K., Binesh N., Davanzo P., Kumar A., Siegel B., Frye M., Curran J., Lufkin R., Martin P., and Guze B. Localized two-dimensional shift correlated MR spectroscopy of human brain. Magnetic Resonance in Medicine 46 (2001) 58-67
38. van der Graaf M., Janssen S.W., van Asten J.J., Hermus A.R., Sweep C.G., Pikkemaat J.A., Martens G.J., and Heerschap A. Metabolic profile of the hippocampus of Zucker diabetic fatty rats assessed by in vivo 1H magnetic resonance spectroscopy. NMR in Biomedicine 17 (2004) 405-410
39. Watari K., Letamendi A., Elderkin-Thompson V., Haroon E., Miller J., Darwin C., and Kumar A. Cognitive function in adults with type 2 diabetes and major depression. Archives of Clinical Neuropsychology 21 (2006) 787-796